コーパス検索結果 (１語後でソート)
通し番号をクリックするとPubMedの該当ページを表示します
1 C4S to inhibit IRBC binding to the placental chondroitin sulfate proteoglycan.
2 y developed antibody, 8B3, that recognizes a chondroitin sulfate proteoglycan.
3 rotein encoded by the sequence secreted as a chondroitin sulfate proteoglycan.
4 DBP, suggesting that the protein binds to a chondroitin sulfate proteoglycan.
5 rons, and of biglycan, a small, leucine-rich chondroitin sulfate proteoglycan.
6 growth cones turn to avoid substratum-bound chondroitin sulfate proteoglycan.
7 ich is consistent with the inhibitor being a chondroitin sulfate proteoglycan.
8 ss-reactivity against versican V2 isoform, a chondroitin sulfate proteoglycan.
9 -type (WT) but not SG-/- platelets contained chondroitin sulfate proteoglycans.
10 degrade the local accumulation of inhibitory chondroitin sulfate proteoglycans.
11 ly inhibitory proteoglycan molecules such as chondroitin sulfate proteoglycans.
12 s assessed by incorporation of Na2(35)SO4 in chondroitin sulfate proteoglycans.
13 s was the major core protein of the secreted chondroitin sulfate proteoglycans.
14 proximately 50%, suggesting association with chondroitin sulfate proteoglycans.
16 ased apoptosis and impaired proliferation of chondroitin sulfate proteoglycan 4 (also known as neuron
19 ical analysis, alpha-smooth muscle actin and chondroitin sulfate proteoglycan 4 staining, microsensor
21 onal antibodies specific to cancer biomarker chondroitin sulfate proteoglycan 4, enabling its detecti
22 ealing only two genes, encoding aggrecan and chondroitin sulfate proteoglycan 4, that were selectivel
24 sent study, we tested whether degradation of chondroitin sulfate proteoglycan, a known inhibitor of a
25 or CNS endocannabinoid, in the modulation of chondroitin sulfate proteoglycan accumulation in Theiler
26 glycoprotein--or reactive astrocyte-produced chondroitin sulfate proteoglycans activates PARP1, resul
30 r subsequent plating, the hyaluronan-binding chondroitin sulfate proteoglycans aggrecan, neurocan, an
33 so resulted in increased immunoreactivity to chondroitin sulfate proteoglycans and a more extensive a
34 an apoE-dependent process that involves both chondroitin sulfate proteoglycans and an alpha(2)M recep
35 ates, including major CNS inhibitors such as chondroitin sulfate proteoglycans and myelin-associated
36 n-induced or revealed inhibitors such as the chondroitin sulfate proteoglycans and the myelin inhibit
37 ini of chains in the biosynthesis pathway of chondroitin sulfate proteoglycans and their modulation i
38 cell adhesion molecule (NCAM), L1, tenascin, chondroitin sulfate proteoglycan, and peanut agglutinin
39 promoting interactions with cell-associated chondroitin sulfate proteoglycans, and by disrupting the
40 percent of proteoglycans on melanocytes are chondroitin sulfate proteoglycans, and the CD44 chondroi
41 FAK) levels and regulate apoptosis through a chondroitin sulfate proteoglycan- and possibly alpha4 in
42 or SOX1; early oligodendroglial markers were chondroitin sulfate proteoglycan antigen and platelet-de
45 the same sulfated molecule, suggesting that chondroitin sulfate proteoglycan binding in this region
46 before drug-treated growth cones contacted a chondroitin sulfate proteoglycan border, they were narro
48 coproteins tenascin-C and tenascin-R and the chondroitin sulfate proteoglycans brevican and neurocan.
50 ates have now been identified, including the chondroitin-sulfate proteoglycans brevican and versican.
51 ate proteoglycans, we show that cell surface chondroitin sulfate proteoglycans can also mediate bindi
52 senchymal (CD10, CD13, and CD90), pericytic (chondroitin sulfate proteoglycan, CD140a, and CD140b), a
55 epidermis suggests that melanoma-associated chondroitin sulfate proteoglycan colocalizes with epider
56 ning for glial fibrillary acidic protein and chondroitin sulfate proteoglycan compared with OEG-only
57 oteoglycan synthesis or removed cell surface chondroitin sulfate proteoglycan completely blocked apoE
58 mAb, scFv 61 immunoprecipitates the >450-kDa chondroitin sulfate proteoglycan component of the HMW-MA
59 ndroitinase ABC, an enzyme that degrades the chondroitin sulfate proteoglycan components of PNNs.
60 ies.SIGNIFICANCE STATEMENT The deposition of chondroitin sulfate proteoglycans contributes to the fai
61 n N-terminal domain similar to the mammalian chondroitin sulfate proteoglycan core protein NG2, a cen
62 he major CNS inhibiting substrates including chondroitin sulfate proteoglycans could inactivate prote
65 on the identification of a cell surface CD44/chondroitin sulfate proteoglycan (CSPG) and alpha 2 beta
66 Fras1 and AMACO interact directly via their chondroitin sulfate proteoglycan (CSPG) and P2 domains.
68 ies have shown that different members of the chondroitin sulfate proteoglycan (CSPG) class of putativ
69 Monoclonal antibody Cat-315 recognizes a chondroitin sulfate proteoglycan (CSPG) expressed on the
70 Monoclonal antibody Cat-301 recognizes a chondroitin sulfate proteoglycan (CSPG) expressed on the
71 ted that DEX treatment significantly reduced chondroitin sulfate proteoglycan (CSPG) expression 1 wee
74 s a chemotactic cofactor, and DBP binds to a chondroitin sulfate proteoglycan (CSPG) on neutrophil pl
77 CGRP) to reveal ascending sensory axons, and chondroitin sulfate proteoglycan (CSPG) to assess the di
82 of heparan sulfate proteoglycans (HSPG) and chondroitin sulfate proteoglycans (CSPG) are required fo
83 the presence of inhibitory molecules, e.g., chondroitin sulfate proteoglycans (CSPG), in the glial s
84 th Tbx20 gain of function, the expression of chondroitin sulfate proteoglycans (CSPG), including aggr
86 rm), and speculate that the higher levels of chondroitin-sulfate proteoglycan (CSPG) in more mature a
91 environment contains both growth-inhibitory chondroitin sulfate proteoglycans (CSPGs) and growth-pro
92 t with the glycosaminoglycan portion of both chondroitin sulfate proteoglycans (CSPGs) and heparan su
95 regeneration by inhibitory molecules such as chondroitin sulfate proteoglycans (CSPGs) and myelin-ass
98 ellular matrix (ECM) proteoglycans, of which chondroitin sulfate proteoglycans (CSPGs) are a major cl
105 Both the sugar chains and core proteins of chondroitin sulfate proteoglycans (CSPGs) are inhibitory
106 Myelin-associated inhibitors (MAIs) and chondroitin sulfate proteoglycans (CSPGs) are major cont
110 ay be affected by upregulation of inhibitory chondroitin sulfate proteoglycans (CSPGs) following vari
111 and extracellular matrix molecules including chondroitin sulfate proteoglycans (CSPGs) found within t
113 ate proteoglycans (HSPGs), the importance of chondroitin sulfate proteoglycans (CSPGs) in modulating
114 4-sulfate (C4S) chains of very low sulfated chondroitin sulfate proteoglycans (CSPGs) in placenta me
115 previously shown that unusually low sulfated chondroitin sulfate proteoglycans (CSPGs) in the intervi
116 per, we reported that unusually low sulfated chondroitin sulfate proteoglycans (CSPGs) in the intervi
118 developing and regenerating nervous system, chondroitin sulfate proteoglycans (CSPGs) inhibit the in
125 e recently shown that unusually low-sulfated chondroitin sulfate proteoglycans (CSPGs) present in the
126 urportedly one of the most growth-inhibitory chondroitin sulfate proteoglycans (CSPGs) produced after
128 n in birds has been attributed to diffusible chondroitin sulfate proteoglycans (CSPGs) secreted by th
129 In this assay, a gradient of inhibitory chondroitin sulfate proteoglycans (CSPGs) stimulates for
130 extracellular matrix molecules laminin-1 and chondroitin sulfate proteoglycans (CSPGs) were determine
133 trocytes form an astroglial scar and produce chondroitin sulfate proteoglycans (CSPGs), activate micr
134 densation with mislocalized distributions of chondroitin sulfate proteoglycans (CSPGs), aggrecan and
135 godendrocyte myelin glycoprotein (OMgp), and chondroitin sulfate proteoglycans (CSPGs), and a key que
136 in-specific member of the lectican family of chondroitin sulfate proteoglycans (CSPGs), may play a ro
137 ction of chondroitinase-ABC, known to digest chondroitin sulfate proteoglycans (CSPGs), prevented the
138 eurons and Golgi neurons and are composed of chondroitin sulfate proteoglycans (CSPGs), tenascin-R (T
139 hibitory activities of myelin components and chondroitin sulfate proteoglycans (CSPGs), the major cla
140 ntaining substantial amounts of glycosylated chondroitin sulfate proteoglycans (CSPGs), whereas glyco
142 xyuridine (BrdU) are closely associated with chondroitin sulfate proteoglycans (CSPGs), which were id
150 e was no increase in the gene expression of "Chondroitin Sulfate Proteoglycans" (CSPGs') clusters.
151 noprecipitation studies to interact with the chondroitin sulfate proteoglycan decorin in the medium o
152 trix molecules was compared with that of the chondroitin sulfate proteoglycan decorin, revealing an a
153 eparan sulfate proteoglycan glypican, or the chondroitin sulfate proteoglycan-degrading enzyme chondr
154 CNS, modulates neuroinflammation and reduces chondroitin sulfate proteoglycan deposition around demye
157 (alpha-smooth muscle actin, desmin, and NG2 chondroitin sulfate proteoglycan), endothelial cells (CD
158 s directed against NG2, an integral membrane chondroitin sulfate proteoglycan expressed by oligodendr
159 man single-chain Fv molecule that binds to a chondroitin sulfate proteoglycan expressed on the surfac
160 th epidermal stem cells, melanoma-associated chondroitin sulfate proteoglycan expression within the h
162 nut agglutinin-binding components, tenascin, chondroitin sulfate proteoglycans, fibronectin, laminin)
163 similar to aggrecan, a high-molecular-weight chondroitin sulfate proteoglycan found in cartilage.
165 the lesion core and a reduced expression of chondroitin sulfate proteoglycan glycosaminoglycan sidec
166 alysis strongly suggest that cell-associated chondroitin sulfate proteoglycans greatly facilitate inf
167 rophic factor (GDNF), but not the removal of chondroitin sulfate proteoglycans, greatly enhanced the
168 ed antigen (HMW-MAA), also known as melanoma chondroitin sulfate proteoglycan, has been used as a tar
169 ated important roles for heparan sulfate and chondroitin sulfate proteoglycans (HSPGs and CSPGs) in a
170 ration assay, we found that both heparan and chondroitin sulfate proteoglycans (HSPGs and CSPGs, resp
172 of the link protein family), in which other chondroitin sulfate proteoglycans (i.e. versican, brevic
174 We now report that type XV collagen is a chondroitin sulfate proteoglycan in human tissues and cu
175 ults indicate an important role of the CSF-1 chondroitin sulfate proteoglycan in in vivo signaling by
176 nding protein)/brevican is the most abundant chondroitin sulfate proteoglycan in the extracellular ma
177 encountered a border between fibronectin and chondroitin sulfate proteoglycan in the presence and abs
180 lvement of plasma membrane-bound heparan and chondroitin sulfate proteoglycans in cellular uptake of
181 the activities of both myelin inhibitors and chondroitin sulfate proteoglycans in inhibiting neurite
182 atterns of hyaluronan and hyaluronan-binding chondroitin sulfate proteoglycans in neural stem cells a
183 We provide evidence for the in vivo role of chondroitin sulfate proteoglycans in Plasmodium falcipar
185 nting the formation of PNNs, suggesting that chondroitin sulfate proteoglycans in the PNNs control pl
186 ndroitinase ABC (ChABC) to cleave inhibitory chondroitin sulfate proteoglycans in the scar matrix.
188 DIMKKTI) that binds to cell surface melanoma chondroitin sulfate proteoglycan, indicating that SG1 re
189 severe glial scar and enhanced expression of chondroitin sulfate proteoglycans, indicative of a more
191 developmentally regulated membrane-spanning chondroitin sulfate proteoglycan is expressed primarily
192 Here we show that NG2, a structurally unique chondroitin sulfate proteoglycan, is a molecular compone
195 for an inhibitory molecule is collagen IX, a chondroitin sulfate proteoglycan made by sclerotome cell
196 results indicate that the core protein of a chondroitin sulfate proteoglycan may also regulate the a
197 rmined by antisense inhibition that melanoma chondroitin sulfate proteoglycan (MCSP) and membrane-typ
200 onoclonal antibody 7.1, which recognizes the chondroitin sulfate proteoglycan molecule NG2, was used
201 y detects the human homologue of the rat NG2 chondroitin sulfate proteoglycan molecule, which has pre
203 e presence of the growth-inhibitory proteins chondroitin sulfate proteoglycan, myelin basic protein,
204 ssing Mfn-2 altered growth cone responses to chondroitin sulfate proteoglycan, netrin-1, and fibronec
206 , we treated rats with the growth-inhibitory chondroitin sulfate proteoglycan neurocan, the growth-st
207 interactions of the nervous tissue-specific chondroitin sulfate proteoglycans neurocan and phosphaca
211 ct populations of glial cells expressing the chondroitin sulfate proteoglycan NG2 have been described
212 Cells expressing the purportedly inhibitory chondroitin sulfate proteoglycan NG2 proliferate in the
213 nteractions of the developmentally regulated chondroitin sulfate proteoglycan NG2 with human plasmino
214 s react with rat neural cells expressing the chondroitin sulfate proteoglycan NG2, which shows 81% ho
219 ssay we have demonstrated that phosphacan, a chondroitin sulfate proteoglycan of nervous tissue that
220 evious studies have shown that versican is a chondroitin sulfate proteoglycan of the ECM that is prod
221 ously that although all antibodies recognize chondroitin sulfate proteoglycans of similar sizes, each
222 the neural matrix is the lectican family of chondroitin sulfate proteoglycans, of which brevican is
223 how that CD44H is expressed as a "part-time" chondroitin sulfate proteoglycan on normal cultured mela
224 chains of heparan sulfate, or in some cases chondroitin sulfate, proteoglycans on the cell surface.
225 that removes CS from its core protein in the chondroitin sulfate proteoglycans or by preventing the f
226 on of inhibitory molecules (such as Nogo and chondroitin sulfate proteoglycans) or administration of
227 h inhibitions from CNS myelin and astroglial chondroitin sulfate proteoglycans partially account for
228 and transforming growth factor-beta2, and of chondroitin sulfate proteoglycans participating in the f
229 lular matrix proteins, and also suggest that chondroitin sulfate proteoglycans play an important role
230 minoglycan (CSGAG), suggesting that melanoma chondroitin sulfate proteoglycan plays a role in modulat
233 picans are secreted or cell-associated brain chondroitin sulfate proteoglycans produced by glia cells
234 ersican (a core protein of one of the matrix chondroitin sulfate proteoglycans) promoter is sufficien
235 effects in part by signaling through the NG2/chondroitin sulfate proteoglycan receptor expressed on t
236 IV)1263-1277 was bound by melanoma cell CD44/chondroitin sulfate proteoglycan receptors and not by th
238 ndroitin sulfate proteoglycans, and the CD44 chondroitin sulfate proteoglycan represented 10% of that
239 as used in early studies to identify a novel chondroitin sulfate proteoglycan, secreted by L-2 cells,
242 monoclonal antibody that recognizes a 680-kD chondroitin sulfate proteoglycan similar to aggrecan, a
244 This apoptotic mechanism was mediated by a chondroitin sulfate proteoglycan, since treating cells w
246 ators pleiotrophin, NrCAM, tenascin, and the chondroitin sulfate proteoglycans, suggesting the import
252 ciated antigen (HMW-MAA) is a membrane-bound chondroitin sulfate proteoglycan that is variably expres
253 reas cyclopamine reduced expression of these chondroitin sulfate proteoglycans that are known to be i
255 was seen in the case of heparan sulfate and chondroitin sulfate proteoglycans that do not possess a
256 nets are composed of lecticans, a family of chondroitin sulfate proteoglycans that includes aggrecan
259 e neurite outgrowth inhibitory properties of chondroitin sulfate proteoglycans, the major inhibitory
261 ich extracellular glycocalyx composed of the chondroitin sulfate-proteoglycan versican bound to a hea
262 in E2), THBS1 (thrombospondin 1), and CSPG2 (chondroitin sulfate proteoglycan; versican) were down-re
263 how that after contact with substratum-bound chondroitin sulfate proteoglycan, vinblastine- and taxol
264 endent neoepitope immunolabeling showed that chondroitin sulfate proteoglycan was thoroughly degraded
265 heparan sulfate proteoglycans but possessing chondroitin sulfate proteoglycans, we show that cell sur
266 intensely for versican, a large interstitial chondroitin sulfate proteoglycan, whereas the collagen-c
267 ecipitated protein and the core protein of a chondroitin sulfate proteoglycan, which is expressed on
WebLSDに未収録の専門用語（用法）は "新規対訳" から投稿できます。